Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Development and validation of a prognostic nomogram model in primary cutaneous and subcutaneous soft tissue angiosarcoma
By
- AMS
posted
Aug 25, 2021 02:03 PM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications
- AMS
Added Sep 10, 2020
Blog Entry
Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States
- AMS
Added Jan 28, 2021
Blog Entry
Private Equity in Aesthetics a New Market Model for Physicians
Prime JOURNAL
Added Jun 09, 2023
Blog Entry
Boost Your Professional Development in Aesthetic Medicine with These Free AMS Features
- AMS
Added May 31, 2023
Blog Entry
Non‐invasive evaluation techniques to efficacy of anti‐cellulite treatment: the high frequency (HF) ultrasound as a useful imaging technique of the skin and subcutaneous tissue
- AMS
Added Aug 11, 2021
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic